Kirby Lee

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Association of trial registration with the results and conclusions of published trials of new oncology drugs
    Nicolas Rasmussen
    History and Philosophy of Science, University of New South Wales, Sydney 2052, Australia
    Trials 10:116. 2009
  2. ncbi Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals
    Kirby P Lee
    University of California, San Francisco, CA, USA
    Med J Aust 184:621-6. 2006
  3. ncbi Has the hunt for conflicts of interest gone too far? No
    Kirby Lee
    Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Box 0613, San Francisco, CA 94118, USA
    BMJ 336:477. 2008
  4. ncbi Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others
    Lisa Bero
    Clinical Pharmacy and Health Policy, University of California, San Francisco, California, United States of America
    PLoS Med 4:e184. 2007
  5. ncbi Publication of clinical trials supporting successful new drug applications: a literature analysis
    Kirby Lee
    Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA
    PLoS Med 5:e191. 2008
  6. ncbi Association of journal quality indicators with methodological quality of clinical research articles
    Kirby P Lee
    Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, CA, USA
    JAMA 287:2805-8. 2002

Detail Information

Publications6

  1. ncbi Association of trial registration with the results and conclusions of published trials of new oncology drugs
    Nicolas Rasmussen
    History and Philosophy of Science, University of New South Wales, Sydney 2052, Australia
    Trials 10:116. 2009
    ..This study compares the prevalence of favorable results and conclusions among published reports of registered and unregistered randomized controlled trials of new oncology drugs...
  2. ncbi Predictors of publication: characteristics of submitted manuscripts associated with acceptance at major biomedical journals
    Kirby P Lee
    University of California, San Francisco, CA, USA
    Med J Aust 184:621-6. 2006
    ..To identify characteristics of submitted manuscripts that are associated with acceptance for publication by major biomedical journals...
  3. ncbi Has the hunt for conflicts of interest gone too far? No
    Kirby Lee
    Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Box 0613, San Francisco, CA 94118, USA
    BMJ 336:477. 2008
  4. ncbi Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others
    Lisa Bero
    Clinical Pharmacy and Health Policy, University of California, San Francisco, California, United States of America
    PLoS Med 4:e184. 2007
    ....
  5. ncbi Publication of clinical trials supporting successful new drug applications: a literature analysis
    Kirby Lee
    Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA
    PLoS Med 5:e191. 2008
    ....
  6. ncbi Association of journal quality indicators with methodological quality of clinical research articles
    Kirby P Lee
    Institute for Health Policy Studies, School of Medicine, University of California, San Francisco, CA, USA
    JAMA 287:2805-8. 2002
    ..CONCLUSIONS: High citation rates, impact factors, and circulation rates, and low manuscript acceptance rates and indexing on Brandon/Hill Library List appear to be predictive of higher methodological quality scores for journal articles...